Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
SLC25A28 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
TMEM140 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IRF1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
OPTN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CBR3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BTN3A2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
MYCBP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SOS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101926887 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RNF114 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ERAP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
C21orf91 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PCGF5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ELK4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF618 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TRIM56 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RNF213 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RTP4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BATF2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on